Connect with us

Technology

Evotec Secures $2.9 Million Grant to Advance Early Drug Safety Testing Using Human Stem Cell Technology

Published

on

New three-year grant from the Gates Foundation extends a 2023 project to help global health researchers predict potential fetal development risks posed by novel drug candidatesEvotec’s human stem cell-based platform enables better-informed decisions regarding which drug candidates to advance into clinical testingContinued collaboration underscores Evotec’s capabilities in advanced human cell-based drug discovery technologies

HAMBURG, Germany, Nov. 16, 2026 /PRNewswire/ — Evotec SE (NASDAQ: EVO) (Frankfurt Prime Standard: EVT) today announced that it has been awarded a new $2.9 million grant by the Gates Foundation to support continued use of its human stem cell-based New Approach Methodologies (NAMs) for identifying potential safety risks to fetal development in novel drug candidates. The funding extends a project initiated in 2023 for a further three years, providing researchers working on global health programs with continued access to technology that can help assess potential risks earlier in drug discovery.

Dr. Joanna Holbrook, Chief Scientific Officer of Evotec, said:
“Identifying potential safety risks early in the drug development process is essential to the efficient advancement of better medicines for global health priorities. Our platform allows researchers to investigate potential effects on prenatal development based on the behavior of human cells, helping them make better-informed decisions about which drug candidates to pursue and minimizing the risk of costly and time-consuming changes in course later in the process. The continued funding support of the Gates Foundation is an important recognition of the potential value of this approach, and we are pleased to extend access to this technology for global health research.”

Evotec’s platform combines human induced pluripotent stem cell (hiPSC) models with industrial-scale screening capabilities to model aspects of human development and to identify compounds that may pose developmental risks.

Over the course of the initial three-year collaboration, more than 5,000 compounds were screened across nine grantee programs, highlighting the platform’s ability to generate human-relevant safety data at scale. The development and validation of the platform are described in a recent bioRxiv preprint.

Evotec’s human stem cell-based platform forms part of its broader capabilities in New Approach Methodologies, which can potentially reduce reliance on animal testing and help improve research efficiency.

About Evotec’s New Approach Methodologies (NAMs)

Evotec is advancing a broad portfolio of human-relevant NAMs designed to support drug discovery and development. Leveraging more than 25 hiPSC-derived cellular models, advanced three-dimensional organoid systems, AI-supported disease modeling and industrial-scale screening platforms, Evotec generates high-quality data for both efficacy and safety assessment. These technologies aim to improve translational relevance and support more predictive decision-making throughout the drug discovery process.

About Evotec’s Human iPSC-Based Teratogenicity Platform

Evotec’s human iPSC-based teratogenicity hazard identification platform provides an in vitro, high-throughput approach for the assessment of potential developmental safety risks in drug discovery. Combining human stem cell-derived models with scalable screening technologies, such as automation and high-content imaging, the platform enables the generation of human-relevant data to support decision-making throughout the drug discovery process. As part of Evotec’s broader New Approach Methodology portfolio, which combines machine learning with high throughput experimentation, high content imaging and interpretable genome-scale molecular data to predict toxicology across organs, the platform is designed to help researchers identify potential safety liabilities earlier in development and advance more predictive, human-relevant approaches to drug discovery and safety assessment.

About Evotec SE

Evotec is a life science company pioneering the future of drug discovery and development. By integrating breakthrough science with AI-driven innovation and advanced technologies, Evotec accelerates the journey from concept to cure with greater speed, intelligence and precision. The company’s expertise spans small molecules, biologics, cell therapies and associated modalities, supported by proprietary platforms including Molecular Patient Databases, PanOmics and induced pluripotent stem cell-based disease modeling. Through flexible partnering models tailored to customers’ needs, Evotec works with all Top 20 pharmaceutical companies, more than 800 biotechnology companies, academic institutions and other healthcare stakeholders. Evotec’s offerings range from standalone services to fully integrated research and development programs and long-term strategic partnerships, combining scientific excellence with operational agility. Through Just – Evotec Biologics, the company is redefining biologics development and manufacturing to improve accessibility and affordability. With a portfolio of more than 100 proprietary research and development assets, most of which are co-owned, Evotec focuses on key therapeutic areas including oncology, cardiovascular and metabolic diseases, neurology and immunology. Evotec’s global team of around 4,500 experts operates from sites in Europe and the United States, providing complementary technologies and services through a network of synergistic centers of excellence. Learn more at www.evotec.com and follow Evotec on LinkedIn and X at @Evotec.

Forward-Looking Statements

This announcement contains forward-looking statements concerning future events, including Evotec’s financial results, full-year 2026 outlook, expected commercial conversion, anticipated strategic partnership and milestone contributions, Horizon implementation, expected cost savings, liquidity, financial flexibility and future business performance. Words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “should,” “target,” “would” and variations of these words and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on information available to Evotec and on expectations and assumptions considered reasonable by the company at the time the statements were made. No assurance can be given that these expectations will prove correct. Forward-looking statements involve known and unknown risks and are based on assumptions and estimates that are inherently subject to significant uncertainties and contingencies, many of which are beyond Evotec’s control. Evotec expressly disclaims any obligation or undertaking to publicly update or revise any forward-looking statements contained in this announcement to reflect changes in expectations, events, conditions or circumstances, except as required by applicable law.

Investor Relations and Media Contact

Dr. Sarah Fakih
EVP Head of Global Communications & Investor Relations
Sarah.Fakih@evotec.com

 

View original content:https://www.prnewswire.com/news-releases/evotec-secures-2-9-million-grant-to-advance-early-drug-safety-testing-using-human-stem-cell-technology-302940114.html

SOURCE Evotec SE

Continue Reading

Technology

DoGo’s Grid-Forming ESS Delivers Round-the-Clock Power to 2,000 Households on Remote Indonesian Island

Published

on

By

JAKARTA, Indonesia, Nov. 16, 2026 /PRNewswire/ — DoGo Power’s Smart grid-forming energy storage system (ESS) and energy management system (EMS) have officially gone live on Pagerungan Kecil Island (P Island), a remote isle off southern Indonesia. The 1MW PV + 2MW/4MWh ESS project brings stable, reliable power to the off-grid community, creating a replicable blueprint for island microgrid deployment across Southeast Asia.

Years of Diesel Reliance and Rationed Power

Cut off from the mainland grid with no subsea cable connection, P Island has long depended on diesel generators for electricity. Home to more than 2,000 fishing households, the island previously served just a quarter of its residents with power, limited to 3–6 hours a day — mostly during daylight hours — with frequent unplanned outages.

At roughly 35 US cents per kilowatt-hour, diesel power was prohibitively expensive, eating up 25% to 40% of many families’ incomes. The chronic power shortage crippled local fishery cold chains and telecom services, and made even basic daily needs — nighttime study, laundry, clinic lighting — a constant struggle.

Grid-Forming Technology Anchors Standalone Microgrid

Engineered for the weak-grid, off-grid conditions of P Island, DoGo’s smart grid-forming ESS, built on its proprietary 4S platform, provides active voltage and frequency regulation to the microgrid with no reliance on external grid support. The solar-plus-storage setup delivers over 20 hours of continuous power daily, covering both residential demand and public service loads.

With no dedicated deep-water port on the island, all equipment — energy storage units, lifting gear and trucks — had to be shipped from neighboring islands and unloaded via temporary pontoons at low tide before being hauled to the project site. DoGo’s 10-foot storage container, weighing in at under 22 tonnes, was purpose-built to stay within the island’s strict hoisting capacity limits. DoGo supplied the full suite of core equipment, including the storage system and EMS, and led end-to-end solution design to ensure robust performance in harsh off-grid conditions.

Tangible Change for 2,000 Island Households

For local families, technical specifications matter far less than the life-altering difference: nights no longer end when the power cuts out.

Stable power is reshaping daily life on the island. “We waited decades for reliable electricity,” said village chief Halilurahman. “We used to take turns using power for just one or two hours each night, watching every minute. When we came back from fishing, our biggest fear was losing our catch to spoilage. Now with solar and storage, we have power to spare. We know life will keep getting better.”

Residents have shifted from rigid, scheduled power use to flexible, on-demand consumption, with many households now purchasing home appliances such as washing machines. Public services — healthcare clinics, schools, telecom networks and clean water systems — and local industries including fishery processing and cold storage all now have uninterrupted power access.

Project data shows electricity costs for the island’s 2,000-plus households have fallen by roughly 81%. The energy storage system achieves 7,300 equivalent utilization hours annually, and is projected to deliver more than 26 million kWh of stable power over its lifecycle, cutting CO₂ emissions by over 22,000 tonnes.

A Benchmark for Remote Island Electrification

The Indonesian government has previously announced a national village-level PV program, which plans to roll out 1MW PV + 4MWh ESS across 80,000 villages nationwide. The P Island project demonstrates the technical and operational viability of grid-forming ESS in remote off-grid island settings, and builds proven delivery expertise for similar deployments.

View original content to download multimedia:https://www.prnewswire.com/news-releases/dogos-grid-forming-ess-delivers-round-the-clock-power-to-2-000-households-on-remote-indonesian-island-302940075.html

SOURCE DoGo Power

Continue Reading

Technology

Formation of the Nomination Committee in Sivers Semiconductors AB ahead of the 2027 Annual General Meeting

Published

on

By

KISTA, Sweden, Nov. 16, 2026 /PRNewswire/ — The Nomination Committee of Sivers Semiconductors AB (the “Company”) shall consist of one member appointed by each of the three largest shareholders in terms of voting rights and the Chairman of the Board of Directors, based on shareholder statistics from Euroclear Nordics AB as of 31 August 2026 and other reliable shareholder information. 

A substantial part of the shares in the Company is held through nominees and custodian banks outside Sweden, whose underlying holders are not identified in the shareholder statistics from Euroclear Nordics AB. Beneficial owners holding shares through such a nominee or custodian who consider themselves to be among the largest shareholders in terms of voting rights are therefore invited to contact the Company no later than 25 November 2026, enclosing documentation evidencing their holding as of 31 August 2026. 

The Chairman of the Board of Directors will thereafter contact the largest shareholders to ascertain whether they wish to appoint members of the Nomination Committee. 

The composition of the Nomination Committee will be published no later than six months before the Annual General Meeting. 

For more information, please contact: 

Company Contact
Heine Thorsgaard 
CFO, Sivers Semiconductors 
Phone: +46 (0)8 703 68 00 
Email: ir@sivers-semiconductors.com

Media Contact   
Tyler Weiland 
Shelton Group
+1-972-571-7834
tweiland@sheltongroup.com

About Sivers Semiconductors 
Sivers Semiconductors is a critical enabler of a greener data economy with energy efficient photonics & wireless solutions. Our differentiated high precision laser and RF beamformer technologies help our customers in key markets such as AI Datacenters, SATCOM, Defense and Telecom solve essential performance challenges while enabling a much greener footprint. For additional information, please visit us at: www.sivers-semiconductors.com (SIVE.ST). 

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/sivers-semiconductors/r/formation-of-the-nomination-committee-in-sivers-semiconductors-ab-ahead-of-the-2027-annual-general-m,c4424401

View original content:https://www.prnewswire.com/news-releases/formation-of-the-nomination-committee-in-sivers-semiconductors-ab-ahead-of-the-2027-annual-general-meeting-302940077.html

SOURCE Sivers Semiconductors

Continue Reading

Technology

Master Concept Partners with ElevenLabs to Accelerate Enterprise Voice AI Adoption

Published

on

By

Bringing natural, intelligent voice interactions into customer experiences and enterprise workflows

HONG KONG, Nov. 16, 2026 /PRNewswire/ — Master Concept, a leading cloud and AI solutions provider in Asia, announces its partnership with ElevenLabs, an AI research and product company, to help enterprises unlock new opportunities in voice-powered AI applications. The collaboration aims to make AI interactions more natural, accessible, and actionable across customer engagement and business operations.

As enterprises accelerate AI adoption, interactions are evolving beyond text-based interfaces toward more intuitive, conversational experiences. Voice AI is becoming an increasingly important interface between people and technology, enabling users to communicate naturally while AI systems understand requests, retrieve information, and perform tasks.

ElevenLabs offers advanced AI voice technologies, including natural-sounding speech synthesis, multilingual capabilities, and conversational AI agents. Its platform enables businesses to build responsive, voice-enabled experiences that can connect with existing knowledge bases and enterprise systems, supporting applications ranging from customer service and virtual assistants to appointment scheduling and interactive commerce.

Through this partnership, Master Concept aims to combine ElevenLabs’ voice AI capabilities with its expertise in cloud infrastructure, enterprise AI, and solution integration. Together, the companies will help organizations explore practical applications of conversational AI, integrate intelligent voice interactions into existing workflows, and move from isolated AI demonstrations toward real business value.

The collaboration also reflects Master Concept’s broader commitment to building a comprehensive enterprise AI ecosystem, connecting innovative AI technologies with the infrastructure, integration expertise, and business understanding required for enterprise adoption.

As AI continues to reshape how people interact with digital services, Master Concept and ElevenLabs look forward to helping businesses create more intuitive, responsive, and human-centered experiences powered by voice AI.

About Master Concept

Master Concept is an Enterprise AI Partner helping organizations turn technology into measurable business value. With more than 20 years of experience across Asia, Master Concept provides consulting, implementation, and services spanning enterprise AI and cloud, cybersecurity and AI governance, digital workplace, data and customer experience, and geospatial intelligence.

About ElevenLabs

ElevenLabs is an AI research and product company. It builds AI voice and audio models, conversational agents, and creative tools to generate and edit content across 90+ languages. Millions of consumers, developers, and businesses use ElevenLabs – including teams at two-thirds of Fortune 500 companies. Across its models and platform, the company aims to transform how people and businesses communicate with the world.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/master-concept-partners-with-elevenlabs-to-accelerate-enterprise-voice-ai-adoption-302939842.html

SOURCE Master Concept

Continue Reading

Trending